Although vessel normalization mediated by blockade of VEGF or ANGPT2 increased the efficacy of chemotherapy in mouse GBM models12,41, it improved the quality of life but not overall survival in human trials14,16. The gene discussed is ANGPT2; the disease is glioblastoma.